Atlas Trials

Host Response to Infection by Direct Analysis of Leukocyte Single Cell-type Gene Expression/transcript Abundance, Direct LS-TA. a Prospective Study Will Evaluate the Performance of Direct LS-TA in Triage Febrile Patients Into Major Categories of Infections: Viral, Bacterial or Active Tuberculosis.

Clinical trial NCT06846645 · NOT_YET_RECRUITING

Trial details

NCT number
NCT06846645
Sponsor
Chinese University of Hong Kong
Status
NOT_YET_RECRUITING
Study type
OBSERVATIONAL
Single Cell Sequencing TechnologyGene Expression ProfilingGene ExpressionInfectionViral DiseasesBacterial DiseasesActive TuberculosisHost Defense MechanismsHost Microbial InteractionsTranscriptome
Start date
2025-02-01
Primary completion
2028-09-01
Enrollment
200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.